Note: Ingredients listed on restricted chemical lists
EC/CAS
57-15-8
Name of the chemical
Chlorobutanol
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2015-06-01
Product name
Thiamine Hydrochloride Injection, USP
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Section 2
Signal word
DANGER. GHS Class: Respiratory sensitisation. Category 1. Reproductive toxicity. Effects on or via lactation.
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. In case of inadequate ventilation wear respiratory protection. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF exposed or concerned: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Contact with eyes may cause irritation. Skin: May cause skin irritation. Inhalation: May cause irritation of respiratory tract. Ingestion: May cause irritation. Signs/Symptoms: Adverse reactions from therapeutic doses include: hypersensitivity or life-threatening anaphylactic reactions, collapse and death have been reported, feeling of warmth, pruritus, urticaria, weakness, sweating, nausea, restlessness, tightness of the throat, angioneurotic, edema, cyanosis, pulmonary edema, and hemorrhage into the gastrointestinal tract. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with a history of sensitivity to thiamine or to any of the ingredients in this product. Conditions: